Former Deputy National Security Advisor Dina Powell McCormick said on Tuesday that recent regional reforms and alliances, including the 2020 Abraham Accords, have been instrumental in the Middle East’s development and its response to the Oct. 7, 2023, Hamas terror attacks and ensuing war in Gaza.

“I think we are moving too fast sometimes, and don’t pause on how critical it is that even after October 7, not one of the signatories of that peace treaty got out,” Powell McCormick said in comments made at the Future Investment Initiative Summit in Riyadh, Saudi Arabia. “And I believe it’s thanks to President [Donald] Trump, thanks to Jared Kushner, thanks to [Special Envoy] Steve Witkoff, the reason that we saw the ceasefire happen, the release of the hostages and Inshallah, God-willing, a more stable Gaza so the humanitarian suffering can end.” 

“I think it’s because, in many ways, the seeds were planted to have last week that announcement not just by the United States, but over 50 countries, again, from Egypt and Jordan, the Emiratis, the Qataris, the Turks, the Pakistanis,” Powell McCormick continued. “This is remarkable.”

Powell McCormick, who served in the first Trump administration and is now vice chairman and president of global client services at BDT-MSD, reflected on a trip to the region nearly a decade ago while working for the White House. “I think if you had told us then that nine years later, you would have seen the economic, social and political gains and transformation that we have seen,” she said, “it would have been hard to believe economically … it would have been hard to imagine that this kingdom and this region of the world is now the dominant source of capital for innovation, the dominant source of capital for the change that we’re witnessing in every industry, artificial intelligence, biotech, robotics, longevity.”

A new bipartisan House bill set to be introduced on Wednesday aims to expand U.S.-Israeli research and development cooperative programs in the medical field. 

The BIRD Health Act, led by Reps. Randy Weber (R-TX) and Chris Pappas (D-NH), builds on the long-running Binational Industrial Research and Development Foundation program. 

Around a third of BIRD projects in the past decade have been related to the health-care sector, and the U.S. and Israel have pursued growing cooperation in the field in recent years. The bill would further formalize those efforts by establishing a new $10 million annual funding stream and joint management structure between the Department of Health and Human Services and the Israeli Ministry of Health specifically focused on supporting such projects.

It would support research and development between institutions and companies in both countries, including startups, as well as health systems, telemedicine, disease prevention efforts and biological product manufacturing.

“The United States and Israel share one of the strongest, most enduring alliances in the world, and it just makes sense to join forces in advancing life-saving health technologies that benefit both our nations,” Weber said in a statement. “The BIRD Health Act of 2025 builds on our shared strengths to support cutting-edge medical innovation, strengthen supply chains, and improve health outcomes for American families.”

“U.S. and Israeli doctors, scientists, and researchers are leading the world in groundbreaking medical advancements, including regenerative medicine, disease prevention, and cancer research,” Pappas said in a statement. “The health technology and innovation program created through this bipartisan legislation will strengthen the bilateral partnership between the U.S. and Israel to address emerging health issues, develop innovative solutions, and save lives.”